GlassScriptPhysician profile
Saqib Zia
NPI 1285812180
$14,233.50
in general payments reported to CMS, 2019-2025
20 companies · $2,352 in 2025
The $2,352 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $4,321 · 2021: $784 · 2022: $292 · 2023: $3,803 · 2024: $1,607 · 2025: $2,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,808 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Travel and Lodging: $1,677 · Grant: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,807.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Travel and Lodging | $1,677.03 |
| Grant | $878.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $4,316.99 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $2,400.00 | 2023 | Indigo System |
| Boston Scientific Corporation | $1,774.38 | 2022-2025 | General - Therapies, Enroute Transcarotid Neuroprotection System, General - Non-Vascular Intervention |
| W. L. Gore & Associates, INC. | $1,527.03 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Endoprosthesis |
| Cook Medical LLC | $1,098.51 | 2019-2025 | Zenith Alpha, Zilver Ptx, Zenith Spiral-Z |
| Cook Incorporated | $878.00 | 2023 | |
| Cardiovascular Systems INC. | $583.72 | 2020-2023 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $549.00 | 2020 | |
| Silk Road Medical, INC. | $239.60 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $188.36 | 2021 | |
| Abbott Laboratories | $139.15 | 2022-2024 | Jeti Peripheral Catheter |
| Bard Peripheral Vascular, INC. | $134.19 | 2019-2024 | Crosser Iq |
| Humacyte Global, INC. | $129.05 | 2025 | Symvess |
| Angiodynamics, INC. | $125.00 | 2024 | Auryon Laser System 100-120 Vac |
| Acera Surgical, INC. | $46.02 | 2025 | Restrata Wound Matrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $28.82 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Tactile Systems Technology INC | $26.70 | 2025 | Nimbl, Flexitouch Plus |
| Axogen | $19.00 | 2025 | |
| Convatec INC. | $16.87 | 2025 | |
| Smith+Nephew, INC. | $13.11 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saqib Zia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.